Toxicogenomics is a combination of functional genomics and molecular toxicology to establish correlations between toxic responses elicited by the toxicants and changes in the genetic profiles of the functions and hence a wider spectrum of the mechanism of toxicity. [1] The GEP approach facilitates the investigation of the molecular mode of action of toxins, prediction of the susceptibility of an individual for the toxic response and the role of modifying factors.
Information obtained from GEP further improves the therapeutic strategies for the treatment of various diseases [2] such as cancer and neurological disorders caused by toxins. The major focus of toxicogenomics is the characterization of changes in gene expression in the cells or tissues following exposure to toxic substances. [3] Toxicogenomics has many advantages over the conventional techniques as it provides more detailed information regarding the molecular mechanisms of toxicity and faster screens for substance toxicity. Following toxicant exposure, gene expression is modulated in a specific and measurable way [4] and that is the main reason why toxicogenomics has advantage over the conventional toxicity testing procedures [ Figure 1 ].
Toxicoproteomics is positioned towards an expanded understanding of protein expression during toxicity and environmental disease for the advancement of public health and seeks to identify critical proteins and pathways affected by and respond to adverse chemical and environmental exposures using global protein expression technologies by integrating traditional toxicology, pathology, differential protein and gene expression analysis, and systems biology. [5] Genes or group of genes influence the outcome of any environmental exposure. An analysis of the toxicological properties of a chemical is estimated to cost huge amount of money, therefore, toxicological properties of approximately 70 000 known chemicals, require several years and thousands of dollars to complete.
Development of cost effective methodologies has
become an essential tool for screening the toxicity of drugs and chemicals [6] that has provided an information on the study of perturbation by chemicals and stressors, monitoring changes in molecular expression and iteratively integrating biological response data to describe the functioning of an organism. [7] Toxicogenomics has provided a tremendous amount of data to support the assessments of human health risk from environmental exposures and correlating them to health endpoints. The national center for toxicogenomics has started developing a public knowledge base called as chemical effects in biological systems (CEBS). The CEBS comprises of molecular expression data sets from transcriptomics, proteomics, metabonomics, and conventional toxicology with metabolic and toxicological pathway and gene regulatory network information relevant to environmental toxicology and human diseases (www.niehs.nih.gov). Council of Scientific and Industrial Research, Government of India has also launched a networked program on 'toxicogenomics of genetic polymorphism in Indian population to industrial chemicals for development of biomarkers' (www.itrcindia.org) for the construction of databases of the gene expression profiles of exposed and unexposed animals, databases of protein profiles in Indian population, databases of single-nucleotide polymorphism (SNP) in the toxicant-responsive genes and protein fingerprints to identify the type of exposure to delineate the mode of action of the various test pollutants. In this review, the contribution of the tools and techniques used in molecular toxicology and its current status in India has been discussed.
Genomics, proteomics, and SNP
A toxicological change at molecular level is accompanied by linking general toxicity with gene expression profiles to improve the sensitivity, accuracy and speed of toxicological investigations. Technologies of genomics and proteomics are being used at different stages of toxicity testing to assess the alteration in the expression of RNA and protein in mechanistic aspects, broader identification of target tissues, long-term 
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Bio-informatics TOXICOGENOMICS exposure consequences to toxic chemicals and reducing ambiguities particularly when toxicities are seen in some but not in all test species. RNA and protein alternations in nonclinical toxicology provide a greater insight and better prediction of the performance of the products during the clinical phase of development.
Toxicogenomics has also become critical for quality control of cell substrates for manufacturing biochemicals to improve the purity, safety and potency of vaccines, blood derivatives, and biological therapeutics. The functional toxicogenomics explains influences and effects measured at the level of the cellular genome and results obtained from histopathological and biochemical tests. Due to recent developments in molecular biology and bioinformatics, it has become possible to analyze protein transcripts (toxicogenomics) and profiles (toxicoproteomics). [8] Environmental and occupational toxic agents that influence cells at the level of transcription and translation have provided new opportunities to study gene sequencing and expression by DNA chip technique. DNA sequencing, transcription profiling and proteomics dealing with DNA, RNA, and proteins provided extensive mechanistic and predictive information about the toxicity of a particular compound.
Although these techniques provide important information like identification of genes, the regulatory elements responsible for the precise environmental and developmental control of gene expression, snapshot of genes being expressed in a particular tissue at a given time, however, these do not always correlate directly with the level or activity of the corresponding protein at a single point of time. [9] Toxicoproteomics is the study of proteins to provide a comprehensive overview of the structure, function and post-translational modifications with special references to toxicology. Recent developments in the molecular tools have fueled an expansion of inventions from simple toxicological estimations of single proteins to measure set of proteins.
Proteomics coupled with advances in bioinformatics has become an essential component of molecular biology.
The SNPs-based studies are also essential component in understanding the actual expression or activity of a protein involved in the toxicity onset or progression.
Microarray
The advent of microarray has allowed toxicologists to analyze the differential expression of thousand and The target DNA may also determine the type of control and sample DNA to be used in the hybridization solution.
A microarray works by exploiting the ability of a given mRNA molecule to bind specifically or hybridize to the DNA template from which it originates.
Researchers have identified a large number of novel toxicant-responsive genes within previously unknown sequences with the help of information available with the microarray. Microarray used for gene expression profiling represents a snapshot of the transcriptional responses at a given time in a particular tissue or organ.
Microarray technology is used to understand fundamental aspects of toxicity as well as to explore the underlying genetic causes of toxicant-induced diseases and disorders. [10] Microarray is also used to characterize genetic diversity, drug responses, identify new drug targets, and assess the toxicological properties of chemicals and pharmaceuticals. The patterns and sequences of gene expressions constitute response 'signatures' unique to specific toxicants or group of toxicants. Microarray has greatly facilitated the development of 'toxchip' containing most of the human genes involved in toxicity responses such as DNA damage, replication and repair, apoptosis, and other cellular responses specific to polycyclic aromatic hydrocarbons (PAHs), dioxins, peroxisomes proliferators, estrogenic compounds, and oxidants. [11] Gene expression profile is used to monitor environmental exposure to chemicals in humans. [11] The mechanism of toxicants exposed to individuals can be clearly understood once the signatures are identified based on the patterns of altered gene expression. 
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interactions is detected by fluorescence imaging or mass spectrometry. Other protein capture methods may be used in place of arrays, including the yeast two-hybrid system or the isolation of protein/protein complexes by affinity chromatography or other separation techniques.
Proteomics approach focuses on the identification of potential early protein biomarkers/signatures, [5] which are indicative of the toxicity or carcinogenesis in exposed animals and are being used to substantially reduce the time and costs of toxicity or carcinogenicity testing. It has also provided potential throughput in the discovery of new biomarkers/toxicity signatures and mapping the serum/plasma and other biological fluid proteomes. [5] Proteomics and metabonomics are used to investigate a link between toxicological studies by giving a way to understand the complex mechanistic pathways. [13] The rapid development of microarray analysis of proteins and the use of tissue arrays for higher throughput biochemical analysis has revolutionized the demands for greater research needs in toxicology. Differential protein expression analysis has also provided a more sensitive indicator of toxicity than the conventional techniques. Epidemiological studies have shown statistically significant association of several factors among which genetic susceptibility is the common factor as indicated by familial aggregation and greater concordance in monozygotic twins with the onset of the diseases such as obesity, cancer, hypertension, and diabetes. [14] The PCR-and sequencing-based techniques have been used to assess the presence of SNPs in a particular gene. Genome-environment interaction among individuals for the susceptibility to a disease greatly varies and Fosmid library allele-specific haplotypes analysis (FLASH) and large insert genome analysis (LIGA) has improved the understanding of genetic variations in various populations. [15] FLASH allows to isolate and sequence fosmid clones that tile a given loci in a haplospecific manner over along genomic region of interest and LIGAN allows the use of end sequence and fingerprint data to identify the variant genomic regions from multiple individuals. [15] FLASH and LIGAN have overcome the limitations of PCR-based re-sequencing methods to screen thousands of individuals. [12] FLASH does not provide phase information for the underlying haplotypes structure of a diploid genome and LIGAN provides a limited resolution at the chromosome level. [15] Telomeric repeat amplification protocol (TRAP), a sensitive, high throughput PCR-based assay provides a reliable tool for the experiments that requires massive quantitation of telomerase activity, however, apyrasemediated allele-specific extension reaction (AMASE) is a novel tool used for microarray-based mutation detection and allows the simultaneous, efficient, and accurate analysis of several samples from different stages of skin malignancies. [16] ' with the aim to systematically identify and characterize common sequence polymorphisms in many genes and their contribution in determining chemical sensitivity. The knowledge gained is exploited to protect susceptible individuals from disease and subsequently to reduce adverse exposure and environmentally induced disease. [4] , [7] The collection of genetic variations serves as a useful resource for analyzing potential association between genotypes and susceptibility to common diseases as well as efficacy and/or adverse reactions to drugs. The utilization of human cancer arrays to profile aberrant gene expression in arsenic-exposed populations in Guizhou, China have provided better understanding of the integral role of arsenic in hepatotoxicity and possibly carcinogenesis. [17] It is also reported that about 60 genes (10%) involved in cell-cycle regulation, apoptosis, DNA damage response and intermediate filaments are differentially expressed in arsenic-exposed human livers as compared with controls. [18] Over expression of endothelins and vascular endothelial growth factor B (VEGF-B) in arsenictransformed rat liver epithelial cells has also suggested a correlation between arsenic-induced portal hypertension and cirrhosis. [18] The influence of geneenvironment interaction in prostate cancer studied in Japanese (NJ) and Japanese-American (JA) men using tissue microarray have shown a historically similar, tissue biomarker expression, especially of lipoxygenase, and the caspase family (e.g., caspase-3) but different mechanism of carcinogenesis. [19] A number of clinically important substrate drugs involve CYP2C9, no 2C9 2(Arg144Cys), or 2C9 3(Ile359Leu) alleles have been reported in Chinese, however, or 2C9 3(Ile359Leu)
SNP
alleles were found to occur in Canadian native Indian. [20] Expression profiling of such polymorphic enzyme could provide an explanation for variable susceptibility of individuals to different drugs or toxins and providing a better prospective for future drugs therapies. [20] The distribution of SNP in the retinoblastoma susceptibility locus (RBI) at 13q14 is being studied in normal Southeast Asian populations (Chinese, Malay, Javanese, Thai, Filipino), South Asian populations (Bangladeshi, Pakistani Pushtun, and Indian) in cases and control subjects and initial findings have suggested that RBI SNP appears to be an ethnic variant in South
Asian populations and hence may be useful for studying RBI inheritance by pedigree analysis. [21] Microarray technology is being applied in cancer research [22] due to its ability to assess the simultaneous expression of many genes. Gene expression profiles of 85 human cancer xenografts with their sensitivities to various drugs have been done and it is reported that 1578 genes were related to chemo-sensitivity; 333 of these genes were associated with two or more drugs and 32 genes were linked with sensitivity to six or seven drugs. [22] The potential involvement of certain signaling and biochemical pathways in drug resistance states of tumor cells could be obtained via ontology-based arrangement of differential gene expression. [22] The application of DNA microarray in the alteration of gene expression has been reported in rats administered with hepatotoxicants such as phenobarbital and carbon tetrachloride. [23] Microarray analysis of T-2 toxin-induced rat fetal brain lesions have also shown that the expression of oxidative stress-related genes, heat shock protein 70 (HSP70), and heme oxygenase (HO) is strongly induced at 12 h after the treatment. [24] In addition, the expression of mitogen-activated protein kinase (MAPK)-related genes (MEKK1 and c-jun) and
apoptosis-related genes (caspase-2), and insulin-like growth factor binding protein-3 (IGF-BP3) were also induced by T-toxin treatment. [25] Calera's amplified
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Sequences are being used to identify unique transcripts of interest. [9] One method, the open method does not rely on previous knowledge of the sequence of the gene of interest, whereas the another method that is closed systems of transcription profiling rely on the defined elements whose function is well understood and for which only expressed sequence tag (EST) is known. [9] cDNA microarray has revolutionized the toxicological studies to a great extent by providing correct assumptions of hazardous chemicals at molecular level. [26] Specific cDNA microarray chips designed for studying toxicant action has made possible to study its action in various organisms and allow simultaneous monitoring of gene expression changes for receptormediated responses, xenobiotic metabolizing enzymes, [27] cell cycle components, oncogenes, tumor suppressor genes, DNA repair genes, estrogenresponsive genes, oxidative stress genes, [27] and genes involved in apoptosis. The expression pattern of 12 000 genes in 3-month-old mice using microarray expression analysis has shown significant changes in the expression of 146 genes associated with UCH-1-dependent metabolic pathways in Parkinson's disease. [27] Subtractive cDNA libraries and microarray analysis for the identification of gene expression profile has provided a way for better understanding of the molecular basis of hypoxia-tolerance by showing how engineered cells survive in the hypoxic environment of the brain parenchyma following transplantation and indicated that the hypoxia-tolerant phenotype is mediated by the active participation of more than hundred genes. [28] Application of DNA microarray to study alcohol-induced liver injury has given important information on the mechanism of action of alcohol in the liver and provided novel approaches to study liver disease. [29] An accurate classification of compounds according to their toxicity mechanism is possible by the combination of well-designed database with appropriate bioinformatics tools. [30] Classification of toxic and nontoxic compounds on the basis of gene expression profiles in a study on male rats treated with various compounds has been done, wherein hepatotoxic and non-hepatotoxic compounds were discriminated on the basis of gene expression profiles. [30] Microarray-based studies have reported the hierarchies of signaling and gene regulatory networks and its disruption leading to birth defects in response to chemicals like antiepileptic drug valproic acid (VPA), a potent inducer of neural tube defects (NTD), and role of histone deacetylase (HDAC) in embryonic development. [31] Global gene expression responses to VPA in mouse embryos during the critical stages of teratogen action in vivo [32] and in cultured P19 embryo carcinoma cells in vitro, have shown that among the VPA-responsive genes, vinculin, metallothioneins 1 and 2, keratin 1-18, etc., are related to NTD or VPA defects, whereas transgelin 2, galectin-1, fatty acid synthase etc., are found to be associated with processes relevant to neural tube formation and closure. [31] Microarray technology in developmental toxicity has been used to understand the mechanistic pathways associated with exposure to pharmaceuticals and environmental chemicals during pregnancy, a burning problem worldwide. [32] Gene expression patterns of chronic arsenic exposed skin, lung, urinary bladder, liver tumors in mice, and subchronic inorganic or organic arsenic exposed v-Ha-ras transgenic mice have shown alterations in toxic manifestations, hepatic arsenic accumulation, and global DNA hypomethylation. [33] The uses of microarray and gel-based expression technologies have shown the effect of phenobarbitol on more than 300 genes in rodent hepatocytes. [34] Serum proteomic pattern diagnostics is a new type of proteomic platform in which patterns of proteomic signatures from high dimensional mass spectrometry data are used as a diagnostic classifier and has shown tremendous promise in early detection of cancers, detection of drug-induced toxicity. [2] Analysis of serum from rat models of anthracycline and anthracenedione induced cardiotoxicity has indicated the potential clinical utility of diagnostic proteomic patterns where low molecular weight peptides and protein fragments have higher accuracy than traditional biomarkers of cardiotoxicity. [35] A novel and relatively simple analytical method for the separation, characterization, and semiquantitation of phospholipids (PLs) from extracts of complex biological samples has been developed that has allowed PL extracts from cells and tissues to be analyzed by liquid chromatography (LC) coupled to electrospray ionization mass spectrometry (ESI-MS). [36] Selection of a potential metabolic marker of phospholipidosis (PLD) has been identified as a lysobis-phosphatidic acid (LBPA) derivative, also known as bis(monoglycero) phosphate (BMP), in quantifiable amounts in the samples from amiodarone-treated rats. [36] Interaction between genetic and environmental factors play a role in many cancers and the genetic make up of an individual affects the vulnerability of an individual to cancer, whereas SNPs contribute to functional variations. The SNPs occur at a frequency of approximately 1 SNP/kb throughout the genome. The frequency range varies from one in 1000 bases to 1 in 100 bases. [37] The SNP typing is a powerful tool for genetic analysis enabling to uncover the association of loci at specific sites in the genome with many disease traits. The establishment of a SNP map of the genome has been possible to detect and map SNPs in the human genome. [38] A SNP, C419A in glyoxalase 1 as autism susceptibility factor has been identified. [39] Acetaminophen (APAP), is hepatotoxic in high doses and a reactive metabolite of APAP reacts with cellular macromolecules causing mitochondrial dysfunction and centrilobular necrosis in the liver that leads up-regulation of stress-related genes such as heme-oxygenase and metallothionein indicating a disruption of energy metabolism and normal metabolic processes. [40] Liver insufficiency is a major cause of death that results from exposures to environmental toxins, specific combinations or doses of pharmaceuticals, and microbial metabolites. [41] It is reported that low nanomolar levels albumin and transferrin. [41] Proteomic and genomic profiling in the acute and chronic brain injuries due to methylazoxymethanol (MAM), a neurotoxicant implicated in Western Pacific ALS, Parkinsonism, Alzheimer-like dementia (ALS/PDC) has been studied. [42] Generation of basic data on sequence polymorphism and its putative influence on gene expression are being extensively used to detect the frequency of (TG/CA) n repeats in human genome. The frequency of (TG/CA) n repeats is known to decrease with the length and longer (TG/CA) is found to be associated with lower expression in a fewer individual genes (IFN-g, EFGR, HSD11B2). [43] , [44] The enormous variability in the sequence of cytochrome P450 gene (CYP) in human liver is the major cause for unpredictable drug response and expression of hepatic gene CYP3A4 in women is reported twice than in men. [45] Pharmacokinetic findings of faster metabolism of CYP3A4 drug substrates in women, further illustrated the contribution of various factors in the expression of CYP in human liver. [45] The SNP-based studies have revealed the correlation of ERalpha polymorphisms with various aspects and emphasized that ER-alpha genotype represent a surrogate marker for predicting breast cancer lymph node studies. [39] Age-incidence patterns of suspected toxicant-induced breast cancer in Asian differ from those in Caucasians. [39] The SNPs found in Spanish and Chueta familial Mediterranean patients with fever and case controls have shown a common feature in all Mediterranean polpulations. [46] Six novel UDPglucuronosyl transferase (UGT1A3) polymorphisms are capable of affecting the steady state levels of estrogens, and may increase sensitivity to adverse drug affects, as studied in Japanese population. [47] The genetic variation in TNF-SF5 was not found to affect tuberculosis susceptibility in Western Africa [48] and a few cases of identical short tandem repeat (STR) haplotypes and SNPs have been detected in Germans, Chinese, and
Thais. [49] The SNPs of the NOD2/CARD15 have also shown to be associated with the development of Crohn's disease in Caucasians but not in Chinese patients. [50] Polymorphism in secreted protein acidic and rich in cysteine (SPARC) in systemic sclerosis (SSc) has been investigated in skin fibroblast. [51] About 0.05% of the Western population is affected with systemic lupus erythematosus and a number of susceptibility loci for SLE have been investigated in an intronic enhancer region. [52] The population differences and marker location within the gene is an important factor in selection of SNPs for use in the study of toxicant-induced complex diseases with linkage or association mapping methods. [53] The microarray-based genotyping has become an alternative for parallel and simultaneous analysis of many SNPs in Finno-Ugric populations. [54] Individuals with polymorphisms in xenobiotic metabolizing enzymes like cytochrome P450s (CYPs), glutathione S-transferase (GSTs), or N-acetyl transferases (NATs) and DNA repair greatly altered susceptibility to various environmentally induced diseases such as cancer, asthma, and central nervous system diseases. [55] It is also reported that DNase1 prevents systemic lupus erythematosus (SLE) by removing DNA from nuclear antigens at sites of high cell turnover. [26] Reports have suggested that the mutation associated with DNase1 is not present in Caucasian, African and Asian on the basis of linkage disequilibria among SNPs, their frequency, location, and haplotype tagging status. [26] Tumor necrosis factor (TNF) and its receptor (TNF-TNFR) super family are known to be involved in the onset of various toxicant-induced diseases and SNPs in these genes have shown different patterns of allele frequency among various populations and thereby indicating varying susceptibility and progression. [56] Schizophrenia, a neurological disease is linked with activation of the immune system and an association between ethnic heterogeneity in 308G/A polymorphisms in TNF gene has been reported in Caucasian, however, no significant association was found in the cases and controls in Asian population. [57] About 2% of the population is affected with psoriasis (OMIM 177900), a chronic inflammatory skin disorder of unknown pathogenesis and SNP lying between SLC9A3R1 and NAT9 leads to its defective regulation by RUNX1, a susceptibility factor for psoriasis. [58] About 20 novel SNPs in the guanine nucleotide binding protein alpha 12-gene locus have been identified in Japanese population. [59] The SNP of growth hormone receptor (GHR) are unevenly distributed in various ethnic groups as evidenced by a study conducted in Chinese Hans ethnic population. [60] Signals of differential demographic history in African-American, East-Asian and European-American populations have been reported by the mathematical formulation for the SNP allele frequency spectrum. [61] The impact of SNP density on fine-scale patterns of linkage disequilibrium (LD) has reflected in a high-resolution study in African-American, Asian, and Caucasian populations. [ conversions in the eNOS gene predispose COPD subjects to the overload of oxidative stress, at least to the reactive nitrogen species. [66] Angiotensin converting enzyme (ACE) and endothelial nitric oxide synthase (eNOS) genes are of particular importance in COPD and the genetic predisposition to lower ACE activity and higher NO level by virtue of the inter-chromosomal cross talk between ACE I and eNOS G alleles involves a mechanism that may avert the pathophysiological severity of COPD. [67] Genetic polymorphisms of GST M1
and GST T1 on susceptibility to cervical cancer in Indian population have revealed a significant difference between the cases and controls in the distribution of the null genotype of GST M1 in individuals of above 45 years; however, no such difference exists for GST T1 null genotype. [44] Imbalance between pro-and antiinflammatory cytokines during inflammation plays a role in pathogenesis of inflammatory bowel disease (IBD) and polymorphism in intron 2 of IL-1RA gene is involved in pathogenesis of IBD in North Indian population has been reported. [68] Alternation in polymorphic frequency of detoxifying genes GSTT1, GSTM1, and GSTP1 have suggested polymorphism in these genes as a potential risk factor for development of bladder cancer. In patients with bladder cancer of North India, frequencies of null genotypes in GSTT1, GSTM1, and GSTP1 were found to be higher in patients as compared with controls. [68] , [69] A detailed RFLP study on 86 patients with cervical cancer and 76 healthy females revealed that CYP2D6 polymorphic genotype is significantly higher in smokers as compared to nonsmokers in cervical cancer. [70] The brain-specific cytochrome P450 2D8 in 50% of human autopsy brains explained the variable analgesic responses to codeine due to genetic polymorphism. [71] Genomics can be used to identify the populations of various ethnic groups that may have different response for toxicity for the same chemical entity. The SNP-based Y-haplotypes are able to distinguish South Indian populations based on Y-specific short repeat tandem markers [72] and such study may be used for the identification of various ethnic groups in Indian population. The SNPs are also important in understanding the mechanism of the pathogenesis of various cardiac diseases and its population-specific prevalence. A possible role of MTHFR A1298C SNP in the pathogenesis of heart diseases has also been found in Tamilians. [73] The SNP in combination with STRs, haplotype based on Y-chromosome-specific short tandem (STR) loci across caste-tribe boundaries in South India has been done and 27 SNPs in the non-recombining region of the Y chromosome has been investigated in 204 individuals belonging to three caste groups (Vizag Brahmins, Peruru Brahmins, Kammas), three tribes (Bagata, Poroja, Valmiki), and an additional group (the Siddis) of African ancestry. [72] The mutation frequency of the MYOC gene is 2% in the Indian population affected with primary open angle glaucoma (POAG), a less studied ethnic group of the Asian continent and a nonsense mutation Gln 368 stop was not found in Indian population as in Japanese population, however, reports exist in Western population. [74] Phase II detoxification genes play a crucial role in the identification of individualistic response for the detoxification of chemicals responsible for the onset or progression of various disorders. Oral cancer is one of the most common cancers in India and phase II enzymes such as glutathione S-transferase M1 and T1 null genotypes (GSTM1 and GSTT1) are considered as the major risk factors. The metabolically generated epoxide intermediates of PAHs are known substrates for GSTM1 and alkyl halides found in cigarette smoke and lipid peroxides. [75] Transcription of the insulin gene involved in putative type 2 diabetes mellitus (T2DM), is regulated by LIM-homeodomain containing protein LMXIA present on 1q21-q23 in Pima Indians and variant screening in Pima Indians has identified seven SNPs throughout the LMXIA locus, however, no evidence for association of any LMXIA SNPs with T2DM was found giving the idea that LMXIA does not contribute significantly to T2DM etiology in Pima Indians. [76] In India, use of genomics and proteomics are only just being realized and there is a long and arduous way to achieve success in this direction. Transcription 
Challenges in toxicogenomics
Toxicogenomics, a tool of unprecedented power in toxicology for understanding and predicting the body's response to toxic exposures has sorted out most of the disputes and problems in toxicology, however, there are still many obstacles and uncertainties remain to be resolved before the toxicogenomic data can get widespread practical and legal applications beyond the research laboratories. Validation of toxicological significance of gene expression changes is required that includes the robustness and reproducibility of toxicogenomic assays between or across different laboratories, species, individuals, tissues, development stages, exposure levels and exposure durations, all of which in one way or another affect gene expression patterns. [77] This technology gave an opportunity to define at unprecedented levels of detail, the molecular events that precede and accompany toxicity, opening the path for better understanding of toxic mechanisms. [27] The major challenge for toxicogenomics in predictive toxicology is the discrimination of changes due to 
